Ziopharm Oncology Aktie Analyse
| 04.04.19 | Ziopharm Oncology Buy | Lake Street | |
| 01.04.19 | Ziopharm Oncology Buy | Laidlaw | |
| 01.06.17 | Ziopharm Oncology Buy | H.C. Wainwright & Co. | |
| 19.07.16 | Ziopharm Oncology Neutral | Mizuho | |
| 11.05.16 | Ziopharm Oncology Neutral | Mizuho | |
| 25.01.16 | Ziopharm Oncology Neutral | Mizuho | |
| 26.06.15 | Ziopharm Oncology Market Perform | BMO Capital Markets | |
| 10.06.15 | Ziopharm Oncology Neutral | Mizuho | |
|
Werbung
|
|||
| 10.03.15 | Ziopharm Oncology Neutral | Mizuho | |
| 02.03.15 | Ziopharm Oncology Buy | Mizuho | |
| 16.01.15 | Ziopharm Oncology Outperform | BMO Capital Markets | |
| 03.03.11 | Ziopharm Oncology overweight | Barclays Capital | |
| 24.02.11 | Ziopharm Oncology overweight | Barclays Capital | |
| 25.06.09 | Ziopharm Oncology | Der Aktionär | |